NK cells and apoptosis

Immunology and Cell Biology

Volumn 77, Issue 1, 1999, Pages 64-75

  Warren, Hilary S ^a   Smyth, Mark J ^b  

^a Australian Capital Territory   (Australia)

^b AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Apoptosis; Fas; Granzymes; Killer Ig like receptors; NK cells; Perforin; TNF

Indexed keywords

FAS ANTIGEN; GRANZYME A; GRANZYME B; IMMUNOGLOBULIN RECEPTOR; PERFORIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIGEN SPECIFICITY; APOPTOSIS; CYTOKINE PRODUCTION; EXOCYTOSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; REVIEW; VIRUS INFECTION;

ANIMALS; APOPTOSIS; BACTERIAL INFECTIONS; CYTOPLASMIC GRANULES; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MODELS, BIOLOGICAL; NEOPLASMS; PARASITIC DISEASES; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; VIRUS DISEASES;

EID: 0032987626     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00790.x     Document Type: Review

References (167)

1. 1 Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood 1995; 85: 2654-70.
2. 2 Trinchieri G. Biology of human natural killer cells. Adv. Immunol. 1989; 47: 187-376.
3. 3 Scott P, Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 1995; 7: 34-40.
4. 4 Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 1993; 5: 503-10.
5. + T cell subsets and induces early resistance to Leischmania major in mice. J. Exp. Med. 1993; 178: 567-77.
6. 6 Winnock M, Barcina MG, Lukomska B et al. Human liver-associated lymphocytes: An overview. J. Gastroenterol. Hepatol. 1995; 10: S43-6.
7. + natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Int. Immunol. 1991; 3: 743-50.
8. -ζ-γ complex expressed on human natural-killer cells. Int. J. Cancer Suppl. 1992; 7: 11-14.
9. + cytotoxic T lymphocytes via CD2, 50 kDa sheep erythrocyte receptor. J. Immunol. 1986; 136: 3939-44.
10. 10 Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol. Rev. 1997; 155: 145-54.
11. x) on myeloid cells is a novel ligand for human CD2. J. Immunol. 1996; 156: 2866-73.
12. 12 Dissen E, Ryan JC, Seaman WE, Fossum S. An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes. J. Exp. Med. 1996; 183: 2197-207.
13. 13 Brown MG, Fulmek S, Matsumoto K et al. A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics 1997; 42: 16-25.
14. 14 Lanier LL, Chang CW, Phillips JH. Human NKR-P1A-A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 1994; 153: 2417-28.
15. 15 Renedo M, Arce I, Rodriguez A et al. The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics 1997; 46: 307-11.
16. 16 Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC, Trucco M. NKR-P1, a novel signal transduction molecule on NK cells. Science 1990; 249: 1298-300.
17. 17 Giorda R, Trucco M. Mouse NKR-P1: A family of genes selectively co-expressed in adherent lymphokine activated killer cells. J. Immunol. 1991; 147: 1701-8.
18. 18 Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu. Rev. Immunol. 1997; 15: 535-62.
19. 19 Ryan JC, Niemi EC, Nakamura MC, Seaman WE. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J. Exp. Med. 1995; 181: 1911-15.
20. + T cells upon NKR-PI cross-linking. J Exp. Med. 1996; 183: 2391-6.
21. 21 Poggi A, Costa P, Tomasello E, Moretta L. IL-12-induced upregulation of NKRP1A expression in human NK cells and consequent NIRPIA-mediated down-regulation of NK cell activation. Eur. J. Immunol. 1998; 28: 1611-16.
22. 22 Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today 1996; 17: 86-91.
23. 23 Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains. Immunity 1995; 2: 439-49.
24. 24 Biassoni R, Cantoni C, Falco M et al. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 1996; 183: 645-50.
25. 25 Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activalory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 1997; 158: 5083-6.
26. 26 Campbell KS, Cella M, Carretero M, Lopez-Botet M, Colonna M. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur. J. Immunol. 1998; 28: 599-609.
27. 27 Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998; 391: 703-7.
28. 28 Moretta A, Sivori S, Vitale M et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 1995; 182: 875-84.
29. 29 Mandelboim O, Kent S, Davis DM et al. Natural killer activating receptors trigger interferon γ secretion from T cells and natural killer cells. Proc. Natl Acad. Sci. USA 1998; 95: 3798-803.
30. 30 Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753-63.
31. 31 Correa I, Corral L, Raulet DH. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur. J. Immunol. 1994; 24: 1323-31.
32. 32 Aramburu J, Balboa MA, Izquierdo M, Lopez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and γ/δ TCR+ T-lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J. Immunol. 1991; 147: 714-21.
33. 33 Chang CW, Rodriguez A, Carretero M. Lopez-Botet M, Phillips JH, Lanier LL. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 1995; 25: 2433-7.
34. 34 Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 1991; 173: 1017-20.
35. 35 Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996; 157: 4741-5.
36. 36 Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 1997; 185: 795-800.
37. 37 Carretero M, Cantoni C, Bellon T et al. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997; 27: 563-7.
38. 38 Cantoni C, Biassoni R, Pende D et al. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur. J. Immunol. 1998; 28: 327-38.
39. 39 Ho EL, Heusel JW, Brown MG, Matsumoto K, Scalzo AA, Yokoyama WM. Murine NKG2D and CD94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc. Natl Acad. Sci. USA 1998; 95: 6320-5.
40. 40 Dissen E, Berg SF, Westgaard IN, Fossum S. Molecular characterization of a gene in the rat homologous to human CD94. Eur. J. Immunol. 1997; 27: 2080-6.
41. 41 Berg SF, Dissen E, Westgaard IH, Fossum S. Two genes in the rat homologous to human NKG2. Eur. J. Immunol. 1998; 28: 444-50.
42. 42 Braud VM, Allan DSJ, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795-9.
43. 43 Perez-Villar JJ, Melero I, Rodriguez A et al. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 1995; 154: 5779-88.
44. 44 Perez-Villar JJ, Carretero M, Navarro F et al. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J. Immunol. 1996; 157: 5367-74.
45. 45 Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998; 8: 693-701.
46. 46 Takei F. The Ly-49 family: Genes, proteins and recognition of class I MHC. Immunol. Rev. 1997; 155: 67-77.
47. + IL-2 activated natural killer cells. Nature 1992; 358: 66-70.
48. 48 Orihuela M, Margulies DH, Yokoyama WM. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc. Natl Acad. Sci. USA 1996; 93: 11 792-7.
49. 49 Brennan J, Takei F, Wong S, Mager DL. Carbohydrate recognition by a natural killer cell receptor, Ly-49C. J. Biol. Chem. 1995; 270: 9691-4.
50. 50 Brennan J, Mahon G, Mager DL, Jefferies WA, Takei F. Recognition of class I major histocompatibility complex molecules by Ly-49: Specificities and domain interactions. J. Exp. Med. 1996; 183: 1553-9.
51. 51 Held W, Cado D, Raulet DH. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J. Exp. Med. 1996; 184: 2037-41.
52. 52 Ortaldo JR, Mason LH, Gregorio TA, Stoll J, Winkler-Pickett RT. The Ly-49 family: Regulation of cytokine production in murine NK cells. J. Leukoc. Biol. 1997; 62: 381-8.
53. 53 Kim S, Yokoyama WM. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement. Cell. Immunol. 1998; 183: 106-12.
54. 54 Mason LH, Anderson SK, Yokoyama WM, Smith HRC, Winkler-Pickett R, Ortaldo JR. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 1996; 184: 2119-28.
55. 55 Mason LH, Willette-Brown J, Anderson SK et al. Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J. Immunol. 1998; 160: 4148-52.
56. 56 Smith KM, Wu J, Bakker ABH, Phillips JH, Lanier LL. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 1998; 161: 7-10.
57. 57 George T, Yu YYL, Liu JX et al. Allorecognition by murine natural killer cells: Lysis of T-lymphoblasts and rejection of bone-marrow grafts. Immunol. Rev. 1997; 155: 29-40.
58. 58 Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J. Immunol. 1998; 160: 87-94.
59. 59 Naper C, Ryan JC, Nakamura MC, Lambracht D, Rolstad B, Vaage JT. Identification of an inhibitory MHC receptor on alloreactive rat natural killer cells. J. Immunol. 1998; 160: 219-24.
60. 60 Berg SF, Dissen E, Westgaard IH, Possum S. Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells. Int. Immunol. 1998; 10: 379-85.
61. 61 Hamann J, Montgomery KT, Lau S, Kucherlapati R, van Lier RAW. AICL: A new activation-induced antigen encoded by the human NK gene complex. Immunogenetics 1997; 45: 295-300.
62. 62 Valiante NM, Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 1993; 178: 1397-406.
63. 63 Sivori S, Vitale M, Morelli L et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 1997; 186: 1129-36.
64. 64 Vitale M, Bottino C, Sivori S et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 1998; 187: 2065-72.
65. 65 Meyaard L, Adema GJ, Chang CW et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997; 7: 283-90.
66. 66 Poggi A, Pella N, Morelli L et al. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur. J. Immunol 1995; 25: 369-76.
67. 67 Poggi A, Tomasello E, Revello V, Nanni L, Costa P, Moretta L. P40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. Int. Immunol. 1997; 9: 1271-9.
68. 68 Henkart PA. Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules. Immunity 1994; 1: 343-6.
69. 69 Podack ER, Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 1983; 302: 442-5.
70. 70 Tschopp J, Nabholz M. Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu. Rev. Immunol. 1990; 8: 279-302.
71. 71 Jenne DE, Tschopp J. Granzymes, a family of serine proteases released from granules of cytolytic T-lymphocytes upon T-cell receptor stimulation. Immunol. Rev. 1988; 103: 53-71.
72. 72 Shinkai Y, Takio K, Okumura K. Homology of perforin to the ninth component of complement (C9). Nature 1988; 334: 525-7.
73. 73 Lichtenheld MG, Olsen KJ, Lu P. Structure and function of human perforin. Nature 1988; 335: 448-51.
74. + T cells. J. Exp. Med. 1990; 171: 1269-81.
75. 75 Nakata M, Smyth MJ, Norihisa Y et al. Constitutive expression of pore-forming protein in peripheral blood gamma delta T cells: Implications for their cytotoxic role in vivo. J. Exp. Med. 1990; 172: 1877-80.
76. 76 Russell JH, Dobos CB. Mechanisms of immune lysis. II. CTL-induced nuclear disintegration of the target begins within minutes of cell contact. J. Immunol. 1980; 125: 1256-61.
77. 77 Duke RC, Chervenak R, Cohen JJ. Endogenous endonuclease-induced DNA fragmentation: An early event in cell-mediated cytolysis. Proc. Natl Acad. Sci. USA 1983; 80: 6361-5.
78. 78 Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J. Exp. Med. 1992; 176: 1521-9.
79. 79 Shiver JW, Su L, Henkart PA. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 1992; 71: 315-22.
80. 80 Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme-B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977-87.
81. 81 Smyth MJ, Trapani JA. Granzymes: Exogenous proteinases that induce target cell apoptosis. Immunol. Today 1995; 16: 202-6.
82. 82 Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell derived granzyme B. Nature 1995; 377: 446-8.
83. 83 Fernandes-Alnemri T, Armstrong R, Krebs J et al. Activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl Acad. Sci. USA 1996; 93: 7464-9.
84. 84 Srinivasula SM, Fernandes-Alnemri T, Zangrilli J et al. The Ced3/interleukin 1 beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2 alpha are substrates for the apoptotic mediator CPP32. J. Biol. Chem. 1996; 271: 27 099-106.
85. 85 Song Q, Burrows SR, Smith G et al. Interleukin-1β converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killing. J. Exp. Med. 1996; 184: 619-26.
86. 86 Sarin A, Williams MS, Alexander-Miller MA, Berzofsky JA, Zacharchuk CM, Henkart PA. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 1997; 6: 209-15.
87. 87 Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74: 845-53.
88. 88 Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-43.
89. 89 Trauth BC, Klas C, Peters AMJ et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301-5.
90. 90 Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell 1996; 85: 817-27.
91. 91 Los M, Van de Craen M, Penning LC et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 1995; 375: 81-3.
92. 92 Yuan J. Transducing signals of life and death. Curr. Opin. Cell Biol. 1997; 9: 247-51.
93. 93 Zheng LX, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995; 377: 348-51.
94. 94 Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995; 373: 438-41.
95. 95 Ju ST, Panka DJ, Cui HL et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-8.
96. 96 Arase H, Arase N, Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp. Med. 1995; 181: 1235-8.
97. 97 Cohen P, Eisenberg RA. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991; 9: 243-69.
98. 98 Korner H, Cook M, Riminton DS et al. Distinct roles for lymphotoxin-a and tumor necrosis factor in organogenesis and spatial organisation of lymphoid tissue. Eur. J. Immunol. 1997; 27: 2600-9.
99. 99 Kagi D, Ledermann B, Burki K et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin deficient mice. Nature 1994; 369: 31-7.
100. 100 Ebnet K, Hausmann M, Lehmann-Grube F et al. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J. 1995; 14: 4230-9.
101. 101 Tay CH, Szomolanyi-Tsuda E, Welsh RM. Control of infections by NK cells. In: Karre K, Colonna M (eds) Specificity, Function, and Development of NK Cells. Berlin: Springer-Verlag, 1998; 193-220.
102. 102 Orange JS, Wang BP, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 1995; 182: 1045-56.
103. 103 Shellam GR, Allan JE, Papadimitriou JM, Bancroft GJ. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl Acad. Sci. USA 1981; 78: 5104-8.
104. 104 Tay CH, Welsh RM. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 1997; 71: 267-75.
105. 105 Paya CV, Kenmotsu N, Schoon RA, Leibson PJ. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J. Immunol. 1988; 141: 1989-95.
106. 106 Salazar-Mather TP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α) -dependent pathways. J. Exp. Med. 1998; 187: 1-14.
107. 107 Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 1990; 171: 1469-83.
108. 108 Farrell HE, Vally H, Lynch DM et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997; 386: 510-14.
109. 109 Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MBA. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 1980; 30: 275-331.
110. 110 Kagi D, Seiler P, Pavlovic J et al. The roles of perforin-and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 1995; 25: 3256-62.
111. 111 Walsh CM, Matloubian M, Liu C-C et al. Immune function in mice lacking the perforin gene. Proc. Natl Acad. Sci. USA 1994; 91: 10 854-8.
112. 112 Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 1996; 14: 207-32.
113. 113 Rossi CP, McAllister A, Tanguy M, Kagi D, Brahic M. Theiler's virus infection of perforin-deficient mice. J. Virol. 1998; 72: 4515-19.
114. 114 Mullbacher A, Ebnet K, Blanden RV et al. Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc. Natl Acad. Sci. USA 1996; 93: 5783-7.
115. 115 Guidotti LG, Ando K, Hobbs MV et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl Acad. Sci. USA 1994; 91: 3764-8.
116. 116 Kagi D, Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 1996; 8: 472-7.
117. 117 Muller U, Steinhoff U, Reis LF et al. Functional role of type I and type II interferons in anti viral defense. Science 1994; 264: 1918-21.
118. 118 Kaufmann SH. Immunity to intracellular bacteria. Annu. Rev. Immunol. 1993; 11: 129-63.
119. 119 Tripp CS, Wolf SF, Unanue ER. Interleukin-12 and tumor necrosis factor-α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with Listeriosis, and interleukin-10 is a physiologic antagonist. Proc. Natl Acad. Sci. USA 1993; 90: 3725-9.
120. 120 Carson WE, Ross ME, Baiocchi RA et al. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 1995; 96: 2578-82.
121. 121 Bigger JE, Thomas CAr, Atherton SS. NK cell modulation of murine cytomegalovirus retinitis. J. Immunol. 1998; 160: 5826-31.
122. 122 Halaas O, Vik R, Espevik T. Induction of Fas ligand in murine bone marrow NK cells by bacterial polysaccharides. J. Immunol. 1998; 160: 4330-6.
123. 123 Scharton-Kersten TM, Sher A. Role of natural killer cells in innate resistance to protozoan infections. Curr. Opin. Immunol. 1997; 9: 44-51.
124. 124 Schito ML, Barta JR. Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice. Infect. Immun. 1997; 65: 3165-70.
125. 125 Babu S, Porte P, Klei TR, Shultz LD, Rajan TV. Host NK cells are required for the growth of the human filarial parasite Brugia malayi in mice. J. Immunol. 1998; 161: 1428-32.
126. 126 Cui J, Shin T, Kawano T et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623-6.
127. 127 van den Broek HF, Kagi D, Zinkernagel RM, Hengartner H. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 1995; 25: 3514-16.
128. 128 van den Broek ME, Kagi D, Ossendorp F et al. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 1996; 184: 1781-90.
129. 129 Smyth MJ, Kelly JM, Baxter AG, Korner H, Sedgwick JD. An essential role for tumor necrosis factor in NK cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 1998; 188: 1611-19.
130. 130 Yu YY, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 1992; 10: 189-213.
131. 131 Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991; 349: 329-31.
132. 132 Bennett M. Biology and genetics of hybrid resistance. Adv. Immunol. 1987; 41: 333-445.
133. 133 Kumar V, George T, Yu YYL, Liu JX, Bennett M. Role of murine NK cells and their receptors in hybrid resistance. Curr. Opin. Immunol. 1997; 9: 52-6.
134. 134 Bennett M, Taylor PA, Austin M et al. Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: Influence of mouse colony environment. Int. Immunol. 1998; 10: 785-90.
135. 135 Baker MB, Podack ER, Levy RB. Perforin-and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice. Biol. Blood Marrow Transplant. 1995; 1: 69-73.
136. 136 Smyth MJ, Thia KYT, Kershaw MH. Xenogeneic mouse antihuman NK cytotoxicity is mediated via perforin. Xenotransplantation 1997; 4: 78-84.
137. 137 Croy BA. Granulated metrial gland cells: Hypotheses concerning possible functions during murine gestation. J. Reprod. Immunol. 1994; 27: 85-94.
138. + cells in the rat uterus: Granulated metrial gland cells are of the natural killer cell lineage. Biol. Reprod. 1994; 51: 509-23.
139. 139 Dietl J, Ruck P, Marzusch K, Horny H-P, Kaiserling E, Handgretninger R. Uterine granular lymphocytes are activated natural killer cells. Immunol. Today 1992; 13: 236.
140. 140 Slukvin II, Merkulova AA, Vodyanik MA, Chernyshov VP. Differential expression of CD45RA and CD45RO molecules on human decidual and peripheral blood lymphocytes at early stage of pregnancy. Am. J. Reprod. Immunol. 1996; 35: 16-22.
141. + NK cells implies they are activated and capable of effector functions. Hum. Reprod. 1993; 8: 2061-7.
142. 142 King A, Jokhi PP, Burrows TD, Gardner L, Sharkey AM, Loke YW. Functions of human decidual NK cells. Am. J. Reprod. Immunol. 1996; 35: 258-60.
143. 143 Miki A, Ishikawa Y, Yabe T et al. Human lymphocytes obtained from decidual tissue express killer activatory receptors as well as killer inhibitory receptors: Analysis using a single strand conformation polymorphism method. Am. J. Reprod. Immunol. 1998; 39: 271-8.
144. 144 Pende D, Sivori S, Accame L et al. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur. J. Immunol. 1997; 27: 1875-80.
145. 145 Soderstrom K, Corliss B, Lanier LL, Phillips JH. CD94/NKG2 is the predominant inhibitory receptor involved in recognition for HLA-G by decidual and peripheral blood NK cells. J. Immunol. 1997; 159: 1072-5.
146. 146 Verma S, King A, Loke YW. Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur. J. Immunol. 1997; 27: 979-83.
147. 147 Rouas-Freiss N, Goncalves RMB, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl Acad. Sci. USA 1997; 94: 11 520-5.
148. 148 Warren HS, Kinnear BF, Phillips JH, Lanier LL. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 1995; 154: 5144-52.
149. 149 Walker C, Checkel J, Cammisuli S, Leibson PJ, Gleich GJ. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J. Immunol. 1998; 161: 1962-9.
150. 150 Warren HS. NK cell proliferation and inflammation. Immunol. Cell Biol. 1996; 74: 473-80.
151. 151 Sulica A, Metes D, Gherman M, Whiteside TL, Herberman RB. Divergent effects of FcγRIIIA ligands on the functional activities of human natural killer cells in vitro. Eur. J. Immunol. 1996; 26: 1199-203.
152. 152 Voss SD, Daley J, Ritz J, Robertson MJ. Participation of the CD94 receptor complex in costimulation of human natural killer cells. J. Immunol. 1998; 160: 1618-26.
153. 153 Bottino C, Sivori S, Vitale M et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur. J. Immunol. 1996; 26: 1816-24.
154. 154 Reichlin A, Yokoyama WM. Natural killer cell proliferation induced by anti-NKI.1 and IL-2. Immunol. Cell Biol. 1998; 76: 143-52.
155. 155 Warren HS, Kinnear BF, Kastelein RL, Lanier LL. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56 (dim)) human NK cells. J. Immunol. 1996; 156: 3254-9.
156. 156 Taga K, Yamauchi A, Kabashima K, Bloom ET, Muller J, Tosato G. Target-induced death by apoptosis in human lymphokine-activated natural killer cells. Blood 1996; 87: 2411-18.
157. 157 Ross ME, Caligiuri MA. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997; 89: 910-18.
158. 158 Azzoni L, Anegon I, Calabretta B, Perussia B. Ligand binding to FcγR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 1995; 154: 491-9.
159. 159 Ida H, Robertson MJ, Voss S, Ritz J, Anderson P. CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. J. Immunol. 1997; 159: 2154-60.
160. 160 Ida H, Anderson P. Activation-induced NK cell death triggered by CD2 stimulation. Eur. J. Immunol. 1998; 28: 1292-300.
161. 161 Jewett A, Cavalcanti M, Bonavida B. Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. J. Immunol. 1997; 159: 4815-22.
162. 162 Ortaldo JR, Winkler-Pickett RT, Nagata S, Ware CF. Fas involvement in human NK cell apoptosis: Lack of a requirement for CD16-mediated events. J. Leukoc. Biol. 1997; 61: 209-15.
163. 163 Eischen CM, Schilling JD, Lynch DH, Krammer PH, Leibson PJ. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 1996; 156: 2693-9.
164. 164 Asea A, Stein-Streilein J. Signalling through NKI.1 triggers NK cells to die but induces NK T tells to produce interleukin-4. Immunology 1998; 93: 296-305.
165. 165 Warren HS, Kinnear BF. Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation. J. Immunol. 1999 (in press).
166. 166 Kersh EN, Shaw AS, Allen PM. Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science 1998; 281: 572-5.
167. 167 Torigoe C, Inman JK, Metzger H. An unusual mechanism for ligand antagonism. Science 1998; 281: 568-72.